The results suggest that ferroptosis is one of the pathological mechanisms underlying cisplatin-induced skeletal muscle atrophy and PD-1 attenuates cisplatin-induced skeletal muscle atrophy by regulating inflammation, OS, autophagy, and ferroptosis. This evidence concerns the gene PDCD1 and muscle atrophy.